Inputs: momentum, trendVelocity
Mixed signal: momentum 46/100, trend 27/100.
Prediction result · Ensemble engineUpdated 6:13 AM
ALMRAlamar Biosciences, Inc. stock price outlook
$30.60-10.11% since prev closeNeutral
Alamar Biosciences, Inc. (ALMR) is trading at $30.6, down 10.11% since the previous close and -0.29% over the past week. Price sits below its 50-day average by 0.15%, with price momentum at 46/100 and trend velocity at 27/100. Sentiment across 7 recent headlines reads mixed at 53/100. Volatility risk is elevated (100/100) and the stock is 57% of the way up its 52-week range. The weighted factor score lands at 39/100 — a neutral signal. Research only, not investment advice.
Universal leanmarket
ALMR
Alamar Biosciences, Inc.
$30.60-10.11%
LEANNEUTRAL / wait for cleaner tape
WHY
- Alamar Biosciences, Inc. (ALMR) is trading at $30.6, down 10.11% since the previous close and -0.29% over the past week. Price sits below its 50-day average by 0.15%, with price momentum at 46/100 and trend velocity at 27/100. Sentiment across 7 recent headlines reads mixed at 53/100. Volatility risk is elevated (100/100) and the stock is 57% of the way up its 52-week range. The weighted factor score lands at 39/100 — a neutral signal. Research only, not investment advice.
- Bull input: No bullish case in the sources.
- Bear input: High volatility (100/100) without momentum support — wide path, more downside variance.
RISK
Signals are model output from public data, not personalized investment advice.
INVALIDATE
Invalidate when a clear catalyst or directional print replaces the mixed tape.
AI Signal
Neutral · Playable
live data
Full public-market mode: chart history, quote, and news inputs were available.
Chart feed
Cron market chart feed
Quote/history
Six-month public chart history loaded.
News feed
7 relevant headlines found.
Signal inputs
Technical factors and news sentiment evaluated across multiple signal inputs.
News Sentiment53/100
Price Momentum46/100
Trend Velocity27/100
Volatility Risk100/100
Historical Modeling: Visualized ranges are mathematically derived from historic volatility metrics, corporate filings, and option-implied volume profiles. They represent statistical points of interest for research purposes, not financial execution commands or advice.
Why It Matters
Signal Explanation
Alamar Biosciences, Inc. (ALMR) is trading at $30.6, down 10.11% since the previous close and -0.29% over the past week. Price sits below its 50-day average by 0.15%, with price momentum at 46/100 and trend velocity at 27/100. Sentiment across 7 recent headlines reads mixed at 53/100. Volatility risk is elevated (100/100) and the stock is 57% of the way up its 52-week range. The weighted factor score lands at 39/100 — a neutral signal. Research only, not investment advice.
Analyst Engine · Specialist model ensemble
Trees disagree — no clear lean on ALMR
Weighted factor score across 16 signal inputs evaluating 9 features: momentum, news, volume, volatility, range, sentiment divergence, trend structure, and oscillator. Consensus and weighting applied. Each specialist bot inspects a different slice of the feature set, casts a directional vote, and contributes a confidence weight to the final score.
Engine edgePlayableNeutral
Inputs: newsSentiment, dayChange
Sentiment 53/100 + price -10.1% are both mid-range.
Inputs: unusualVolume, dayChange
Volume read 29/100 with price drift -10.1% — no clear footprint.
Inputs: volatilityRisk, momentum
High volatility (100/100) without momentum support — wide path, more downside variance.
Inputs: pctOfRange, trendVelocity
Mid-range positioning — no edge from range alone.
Inputs: newsSentiment, weekChange
Sentiment 53/100 vs week change -0.3% are in agreement — no divergence edge.
Inputs: vsSma50, momentum
Price within 0.1% of the 50d SMA — no clear structural read.
Inputs: momentum, trendVelocity
Oscillator at 37 — neutral zone.
Inputs: momentum, dayChange, vsSma50
Momentum 46/100 is not strong enough to confirm a breakout.
Inputs: newsSentiment, weekChange
News 53/100 and weekly change -0.3% do not create a clean follow-through read.
Inputs: unusualVolume, trendVelocity
Volume 29/100 is quiet and trend velocity is weak — move lacks sponsorship.
Inputs: volatilityRisk, pctOfRange, momentum
Volatility 100/100 does not give a clean compression read.
Inputs: pctOfRange, dayChange, weekChange
Range position 57% is too middle-of-the-road to matter.
Inputs: newsSentiment, momentum, weekChange
Sentiment 53/100 and momentum 46/100 are not aligned enough for a clean read.
Inputs: vsSma50, momentum, trendVelocity
50d SMA distance -0.1% is not decisive.
Inputs: momentum, trendVelocity, weekChange
Oscillator at 37 does not show a rebound edge.
Why the ensemble agrees
- Mixed signal: momentum 46/100, trend 27/100.
- Sentiment 53/100 + price -10.1% are both mid-range.
- Price within 0.1% of the 50d SMA — no clear structural read.
Counter-trees
- High volatility (100/100) without momentum support — wide path, more downside variance.
- Volume 29/100 is quiet and trend velocity is weak — move lacks sponsorship.
Bull Case
- No bullish case in the sources.
Bear Case
- High volatility (100/100) without momentum support — wide path, more downside variance.
- Volume 29/100 is quiet and trend velocity is weak — move lacks sponsorship.
Latest Market Headlines
Headline titles only, from the publisher named on each card. Each links to the original story.
Yahoo Finance Singapore57
Alamar Biosciences, Inc. (ALMR) stock price, news, quote and history - Yahoo Finance Singapore
10/29/2026, 9:02:49 AM
Moomoo54
Alamar Biosciences(ALMR.US) 10% Shareholder Sells US$8.57 Million in Common Stock - Moomoo
10/27/2026, 10:14:42 PM
GuruFocus55
Alamar Biosciences (ALMR) Highlights Breakthrough ALS Protein Si - GuruFocus
10/28/2026, 10:45:28 PM
MarketBeat52
Alamar Biosciences (NASDAQ:ALMR) Stock: Insider Corporate Gp Vi Ltd. Qiming Sells 100,837 Shares - MarketBeat
10/29/2026, 9:11:39 PM
Stock Titan53
185,731 Alamar Biosciences (ALMR) shares were sold by Qiming holders over two days. - Stock Titan
10/29/2026, 8:09:44 PM
Key stats
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Market cap
- $2.12B
- 52-week range
- $39.61/$18.845
- Volume
- 740,095
- Avg volume
- 572,574
- Analyst 1-yr target
- $34.00
- Exchange
- NASDAQ-GS
Source: Nasdaq public quote data. Research only.
Insider trades
0 buys · 24 sells by ALMR insiders (SEC Form 4 filings)
- SELL Qiming Corporate GP VI, Ltd. 10% Owner · 2026-10-23$2.72M
- SELL Qiming Corporate GP VI, Ltd. 10% Owner · 2026-10-23$1.34M
- SELL Qiming Corporate GP VI, Ltd. 10% Owner · 2026-10-23$1.09M
- SELL Qiming Corporate GP VI, Ltd. 10% Owner · 2026-10-23$761K
- SELL Qiming Corporate GP VI, Ltd. 10% Owner · 2026-10-23$749K
- SELL Qiming Corporate GP VI, Ltd. 10% Owner · 2026-10-23$639K
Earnings Intelligence
Next
Nov 3, 2026
Estimate
$-0.22
Actual
$-0.22
- • Last report Aug 10, 2026 (Jun 2026): EPS $-0.22 vs $-0.36 expected, +38.89% surprise.
- • Beat estimates in 1 of the last 1 quarters.
- • Next report expected Nov 3, 2026, consensus EPS $-0.22 (Zacks estimate via Nasdaq; the company may confirm a different date).
Risk Warnings
- • Signals are model output from public data, not personalized investment advice.
- • High volatility — position sizing and stops matter more here.
- • Confirm liquidity, spreads, and your own thesis before acting.
ALMR questions
What is the MarketPicks AI signal for Alamar Biosciences, Inc. stock (ALMR)?
As of Nov 2, 1:13 AM ET, the ensemble reads neutral on ALMR — no consensus — 14 of 16 bots holding, with 0 bull, 2 bear and 14 hold votes from 16 specialist bots. Research only, not investment advice.
What is the latest ALMR price on MarketPicks?
ALMR was $30.60 on the latest quote (Nov 2, 1:13 AM ET), -10.11% since the previous close. Quotes can be delayed.
What do the momentum and trend scores for ALMR mean?
Scores run from 0 to 100, with 50 neutral. ALMR shows momentum 46/100, trend velocity 27/100 and volatility risk 100/100, with news sentiment at 53/100.
Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.